Comments
Loading...

Integrated Diagnostics Analyst Ratings

IDGXFOTCPK
Logo brought to you by Benzinga Data
$0.3200
At close: May 12, 9:30 AM EDT

Integrated Diagnostics Analyst Ratings and Price Targets | OTC:IDGXF | Benzinga

Integrated Diagnostics Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Integrated Diagnostics Corp from these most-recent analyst ratings.

Analyst Ratings for Integrated Diagnostics

Buy NowGet Alert
No data available to display

FAQ

Q

What is the target price for Integrated Diagnostics (IDGXF) stock?

A

There is no price target for Integrated Diagnostics

Q

What is the most recent analyst rating for Integrated Diagnostics (IDGXF)?

A

There is no analyst for Integrated Diagnostics

Q

When was the last upgrade for Integrated Diagnostics (IDGXF)?

A

There is no last upgrade for Integrated Diagnostics

Q

When was the last downgrade for Integrated Diagnostics (IDGXF)?

A

There is no last downgrade for Integrated Diagnostics.

Q

When is the next analyst rating going to be posted or updated for Integrated Diagnostics (IDGXF)?

A

There is no next analyst rating for Integrated Diagnostics.

Q

Is the Analyst Rating Integrated Diagnostics (IDGXF) correct?

A

There is no next analyst rating for Integrated Diagnostics.

Browse analyst ratings and price targets on all stocks.